Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-h7n9 fully human monoclonal antibody 8d11 and its preparation method and application

A monoclonal antibody, 8D11 technology, applied in the field of immunology, can solve the problems of no effective treatment, drug resistance, etc., and achieve the effect of high affinity and specificity, good biocompatibility, simple and fast operation

Active Publication Date: 2022-03-25
SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

H7N9 virus is a kind of influenza virus, which is resistant to the traditional antiviral drugs amantadine and rimantadine, and there is no effective treatment at present

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-h7n9 fully human monoclonal antibody 8d11 and its preparation method and application
  • Anti-h7n9 fully human monoclonal antibody 8d11 and its preparation method and application
  • Anti-h7n9 fully human monoclonal antibody 8d11 and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] (1) Construction of NTH-3T3 cell line stably expressing CD40L (3T3-CD40L)

[0054] 3T3-CD40L feeder cells were established using lentivirus. The lentiviral expression vector pLVX-CD40L was constructed and transfected into 293T cells, and the viral supernatant was collected on the fourth day of transfection. NIH-3T3 cells were activated, cultured for 3 passages, infected with lentivirus, and continued to be cultured and passaged 3 times. Cells with FITC fluorescence intensity near MFI were sorted by flow cytometer, added back to the culture flask, 37°C, 5% CO 2 Cultivate and test in an incubator, and the test results are as follows figure 1 As shown, 3T3 cells expressing CD40L and 3T3 cells transfected with empty vector pLVX (with ZxGreen) were stained with anti-CD40L with APC, respectively, and then analyzed by flow cytometry. It was found that all 3T3-CD40L feeder cells expressed CD40L. When the cells grow to 80% to 90%, digest and collect the cells at a concentrat...

Embodiment 2

[0075] Example 2 Cloning, recombination, expression and purification of humanized monoclonal antibody 8D11 gene

[0076] The B cells that can secrete the 8D11 antibody binding to H7N9 virus obtained in Example 1 were lysed, and the lysate was taken for reverse transcription of RNA to obtain the PCR template cDNA of the human antibody gene. Primers for cloning antibody genes were designed and synthesized, genes for heavy and light chains of antibodies were cloned using cDNA as a template, and recombinants were expressed and purified in eukaryotic cells 293F or HEK293. specifically:

[0077] (1) Transfer the lysed B cell solution to a 96-well plate (Eppendorf, 030133366).

[0078] (2) Reverse transcription system: 150ng random primer (Invitrogen, 48190-011), 0.5 μl 10mM dNTP (Invitrogen, 18427-088), 1 μl 0.1M DTT (Invitrogen, 18080-044), 0.5% v / v Igepal CA -630 (Sigma, I3021-50ML), 4U RNAsin (Promega), 6U Prime RNAse Inhibitor (Eppendorf) and 50UIII reverse transcriptase (Invi...

Embodiment 3

[0132] Example 3 Neutralization test and antibody affinity test of purified fully human monoclonal antibody 8D11

[0133] (1) The purpose of the experiment

[0134] Using a virus-infected cell model (canine kidney cell MDCK), the inhibitory effect and effect of 8D11 antibody on H7N9 influenza virus were evaluated by micro-neutralization-ELISA experiment, and the anti-influenza virus activity of the antibody was detected.

[0135] (2) Experimental steps

[0136] (2.1) Cell plating

[0137] MDCK canine kidney cells in logarithmic growth phase were digested with trypsin, collected by centrifugation after termination, and blown evenly to prepare a single cell suspension; the cell concentration was adjusted to 5×10 with cell culture medium 4 cells / ml, seeded in 96-well cell culture plates, cells were placed at 37°C, 5% CO 2 Incubate overnight in an incubator.

[0138] (2.2) Pretreatment of 8D11 antibody and H7N9 virus (the virus A / Anhui / 1 / 2013 was taken from the Institute of Mi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
Login to View More

Abstract

The invention relates to an anti-H7N9 fully human monoclonal antibody 8D11 and its preparation method and application. The fully human monoclonal antibody 8D11 was rapidly screened by memory B cell PCR method without any mouse components. The antibody of the present invention can target the hemagglutinin HA of H7N9 virus, and has a significant neutralizing activity against H7N9 virus infection; the antibody of the present invention does not produce toxic and side effects such as anti-mouse anti-antibody, has better biocompatibility, and is more It is suitable and has more potential to become a macromolecular drug for treating influenza virus.

Description

technical field [0001] The invention belongs to the field of immunology, and in particular relates to an anti-H7N9 fully human monoclonal antibody 8D11 and a preparation method and application thereof. Background technique [0002] Among the top ten best-selling drugs in the world in 2015, 6 are fully human or humanized monoclonal antibody drugs. The number one is Humira, AbbVie's anti-TNFa monoclonal antibody for the treatment of arthritis, which is a fully human monoclonal antibody and has been the drug king with sales of more than 10 billion for three consecutive years. Since the first monoclonal antibody drug was launched in 1986, monoclonal antibody drugs have experienced mouse-derived monoclonal antibody drugs (such as Orthoclone OKT3), chimeric monoclonal antibody drugs (Rituximab), humanized monoclonal antibody drugs (Herceptin) and fully human The original monoclonal antibody drug (Humira) and other stages. Due to the occurrence of anti-mouse antibody reaction (HA...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/10C12N15/13A61K39/42A61P31/16G01N33/577G01N33/569
CPCC07K16/1018A61P31/16G01N33/577G01N33/56983C07K2317/24C07K2317/565C07K2317/56C07K2317/76C07K2317/92
Inventor 万晓春陈有海李俊鑫
Owner SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com